Kevin Richard Haas - 02 Feb 2026 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Chief Technology Officer
Signature: By: Justin Hunter For: Kevin Richard Haas
Issuer symbol: MYGN
Transactions as of: 02 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 03 Feb 2026, 17:29:58 UTC
Previous filing: 25 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Haas Kevin Richard	Chief Technology Officer	322 NORTH 2200 WEST, SALT LAKE CITY	By: Justin Hunter For: Kevin Richard Haas	03 Feb 2026	0001843872

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MYGN	Common Stock	Award	$0	+23,697	+13%	$0.000000	202,332	02 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026.

Content

Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026.